Delaware Chapter of the American College of CardiologyOur purpose is to contribute to the prevention of cardiovascular diseases, to ensure optimal quality of care for individuals with such diseases, and to foster the highest professional ethical standards. Please let us know what information you want to see here. Feel free to contact us with your ideas, needs and comments. |
|
ACC Live Courses For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings |
Latest in Cardiology from ACC.org
- ACCEL Lite: Managing Subclinical AFib Detected by Devices, Ambulatory Monitors and WearablesIn this interview, W. Douglas Weaver MD, MACC and Deepak Bhakta, MD, MBA, FACC discuss managing subclinical AFib detected by devices, ambulatory monitors and wearables.
- 2026 Care of the Athletic Heart Take-Home PointsThe 2026 Care of the Athletic Heart was a 1-day preconference held in advance of the American College of Cardiology Annual Scientific Session. The session, hosted by Dr. Jeffrey Hsu, welcomed guests from over 14 countries and aimed to deliver focused, practical updates in sports cardiology, while providing education and insight into this rapidly evolving […]
- ACC, Other CV Societies Urge Withdrawal of OMB Research Funding ProposalThe ACC, joined by the American Society of Echocardiography, the American Society of Nuclear Cardiology, the Society for Cardiovascular Angiography & Interventions, and the Society of Cardiovascular Computed Tomography, has submitted comments to the Office of Management and Budget (OMB) expressing significant concerns with proposed revisions to the Uniform Guidance governing federal financial assistance programs.
- Safety of Antiarrhythmic Agents in Breastfeeding WomenAccording to the American Academy of Pediatrics (APA) and the World Health Organization (WHO), exclusive breastfeeding is recommended for the first 6 months of infant life, with continuation up to 2 years or as long as mutually desired by the lactating individual and infant.
- Novel TEER System Safe, Effective For High-Risk Primary MR PatientsFor high-risk patients with primary mitral valve regurgitation (MR), the novel Neonova transcatheter edge-to-edge repair (TEER) system was safe and effective, with a high rate of event-free survival and sustained clinical and echocardiographic improvements through two years, according to a prospective study published June 29 in JACC: Asia.



